Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the ra
BIO-RESORT
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials | Cardiovascular Diabetology | Full Text
Trial Scorecard: BIO-RESORT (TWENTE III)
Favorable Outcomes for Orsiro DES presented at EuroPCR in the Five-Year BIO- RESORT Small Vessels Subgroup Analysis | DAIC
Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents | Circulation: Cardiovascular Interventions
BIOTRONIK UK on Twitter: "Three-year outcomes from BIO-RESORT #clinicalstudy, an analysis of #stent treatment in small #coronaryvessels, showed a significantly lower rate of #TLR with BIOTRONIK's #Orsiro ultrathin #DES. Important update: https://t.co ...
BIO-RESORT Silent Diabetes | tctmd.com
Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): Rationale and st
Orsiro DES Shows Lowest Two-Year Target Lesion Failure in BIO-RESORT Trial | DAIC
Favorable Outcomes for Orsiro DES presented at EuroPCR in the Five-Year BIO- RESORT Small Vessels Subgroup Analysis | DAIC
BIO-RESORT (TWENTE III): A prospective, randomized, three-arm trial comparing two different biodegradable polymer-based drug-eluting stents and a durable. - ppt download
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels:
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial - The Lancet
National Institute for Trial Advocacy | Facebook
2-year outcome of the 3-arm BIO-RESORT randomised trial in all-comer patients treated with contemporary DES
High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents
BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease
BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease
Stents Drug Eluting | DAIC
BIO-RESORT (TWENTE III): A prospective, randomized, three-arm trial comparing two different biodegradable polymer-based drug-eluting stents and a durable. - ppt download
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score–Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents | JACC: Cardiovascular Interventions
Trial Scorecard: BIO-RESORT
3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT | tctmd.com
Orsiro Mission | Orsiro US
